SELLAS Life Sciences Group Statistics
NASDAQ: SLSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
13.66-1.20 (-8.08%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
SELLAS Life Sciences Group by the numbers
SELLAS Life Sciences Group has a market capitalization of $2.78 billion based on 203.86M shares outstanding. With trailing EPS of $-0.20, SELLAS Life Sciences Group is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 22.4% above its 50-day average and 50.9% above its 200-day average.
Average daily trading volume is 9.64M shares, or about $131.7 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SLS valuation vs. peer median
| Metric | SLS | Peer median | Difference |
|---|---|---|---|
| Market cap | $2.78B | $2.87B | -3% |
| Avg. volume | 9.64M | 1.86M | +418% |
Peer median across 8 companies: TLX, DYN, ZLAB, ACAD, LEGN, XNCR, BHC, IDYA.
Valuation
- Market cap
- $2.78B
- EPS (TTM)
- $-0.20
- Shares outstanding
- 203.86M
Price and trading
- Previous close
- 14.86
- Open
- 14.97
- Day range
- 13.39 – 15.19
- 52-week range
- 1.39 – 24.89
- 52-week change
- +792.81%
- Beta
- —
- Volume
- 15.37M
- Average volume
- 9.64M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 2.78B
- Forward Pe
- -55.76
- Eps
- -0.20
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 24.89
- Week52 Low
- 1.39
- Avg Volume
- 9.64M
- Shares Outstanding
- 203.86M
- Ma50
- 11.16
- Ma200
- 9.05
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -45.12%
- Pct From52w Low
- 882.73%